Target Research Articles

1. Does TSLP Inhibition Signal The Next Wave Of Respiratory Biologics? 4/1/2026

   Thymic stromal lymphopoietin (TSLP) inhibition has firmly established itself as a strategy in respiratory disease. This article highlights some promising drug candidates and next-generation approaches.

2. The Missing Data Set In Drug Discovery: Patient Experience As Decision Data 3/30/2026

   Drug discovery has become highly effective at capturing molecular detail, yet the experience of disease remains difficult to incorporate into early scientific decisions.

3. What's Next For ADCs: How Combinations Will Help Define The Future Of Treatment 3/23/2026

   Insights gained from advancing ADC combination therapies in lung cancer are now shaping innovative approaches across multiple tumor types.

4. Rethinking Tau Biology: The Future Of Neurodegenerative Drug Discovery 3/19/2026

   We caught up with Melissa Murray, Ph.D., and Amy Rommel, Ph.D., to discuss tau-associated neurodegenerative diseases.

5. Proteomics Biomarkers Beyond Blood 3/16/2026

   Effective biomarker strategies have the potential to accelerate decision-making, de-risk development, and help drive precision medicine.

6. The Advantages Of Antibodies Over Ligands In The Alpha Emitter Era 3/5/2026

   The alpha era in radiopharmaceuticals is still being defined. The choices developers make now about delivery platforms will shape individual programs and the trajectory of the field.

7. Proteomics Tools: A Resurrection 3/4/2026

   For decades, the evolution of proteomics has lagged. Now, a resurrection is underway. New tools are dismantling limitations, signifying a maturation of systems biology.

8. Video Spotlight: Harvard's Alice Stanton On Engineering Integrated Human-Derived miBrain Organoid Models 3/3/2026

   Alice Stanton, PhD, member of the faculty, Harvard Medical School, engineered the first 3D immuno-glial-neurovascular human multicellular integrated brain (miBrain) model. In this video spotlight interview, Dr. Stanton shares her journey into science and neural organoid research.

9. Elusive Success Of CDK2: Why That May Be Changing 3/2/2026

   Cyclin-dependent kinase 2 has eluded clinical validation, but that may be changing.

10. Structural Biology Wages War On HIV And The Pandemics Of Tomorrow 2/27/2026

    Imagine waking up to news of another outbreak — masks, lockdowns, lives upended. But what if we could stop the next one before it starts?